Recall D-0213-2025

US Class II Ongoing · initiated 2025-01-17

Recalling firm

McKesson, TX

Product

Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01

Reason for recall

cGMP Deviations: Product intended for quarantine was inadvertently distributed.

← All recalls